WHO: New vaccines help fight antibiotic resistance 'Silent' pandemic of antimicrobial resistance is a growing public health challenge. About five million people die every year from resistant bacterial infections alone, with 1.27 million deaths directly related to drug resistance.. But resistance doesn't just affect bacterial infections.. Resistance occurs when bacteria, viruses, fungi, and parasites change and stop responding to drugs and are difficult to treat..

Vaccines are effective tools to prevent infections, including those resistant to antimicrobials. WHO has identified sixty-one vaccines that are undergoing various stages of clinical development and testing. The report notes that most of them will not be available anytime soon..

“Prevention of infections through vaccination reduces the use of antibiotics, which reduces the spread of resistance. However, of the six major bacterial pathogens responsible for death due to resistance, only one, pneumococcus, has a vaccine, said Hanan Balkhi, WHO Assistant Director-General. “Equal access to affordable life-saving vaccines such as the pneumococcal vaccine is urgently needed to save lives and prevent resistance.”.

WHO calls for universal access to existing vaccines, especially among resource-poor populations. Vaccines against four priority bacterial pathogens:

pneumococcus, Haemophilus influenzae, tuberculosis, and typhoid have already been developed. BCG - tuberculosis vaccine - does not provide complete protection according to experts.

“Vaccine development is costly and scientifically difficult, often with a high failure rate, and successful candidates go through a difficult process.. We must learn from COVID-19 vaccine development and accelerate the search for vaccines to combat antimicrobial resistance? ,"

https://chronika. info/ Keywords:.